Jpmorgan Chase & CO Zivo Bioscience, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
About Zivo Bioscience, Inc.
- Ticker ZIVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,419,660
- Market Cap $205M
- Description
- ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietar...